{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:53:15Z","timestamp":1786985595380,"version":"build-2736575974"},"reference-count":41,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Jiangsu Health International Exchange Program (China)"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Genetics"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.cancergen.2016.04.001","type":"journal-article","created":{"date-parts":[[2016,4,8]],"date-time":"2016-04-08T11:04:27Z","timestamp":1460113467000},"page":"205-214","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Whole-arm translocation of der(5;17)(p10;q10) with concurrent TP53 mutations in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS): A unique molecular-cytogenetic subgroup"],"prefix":"10.1016","volume":"209","author":[{"given":"Ming","family":"Hong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suyang","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyur P.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hagop M.","family":"Kantarjian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Garcia-Manero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Cameron","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Jeffrey","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9916-5064","authenticated-orcid":false,"given":"Xinyan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergen.2016.04.001_bib0010","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/leu.2008.375","article-title":"The prognostic impact of 17p (p53) deletion in 2272 adults with acute myeloid leukemia","volume":"23","author":"Seifert","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergen.2016.04.001_bib0015","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1200\/JCO.2011.35.6394","article-title":"New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international database merge","volume":"30","author":"Schanz","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cancergen.2016.04.001_bib0020","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1053\/j.seminoncol.2008.04.012","article-title":"Therapy-related myeloid leukemia","volume":"35","author":"Godley","year":"2008","journal-title":"Semin Oncol"},{"key":"10.1016\/j.cancergen.2016.04.001_bib0025","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1182\/blood-2010-08-301713","article-title":"The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AML","volume":"117","author":"Kayser","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2016.04.001_bib0030","doi-asserted-by":"crossref","first-page":"4791","DOI":"10.1200\/JCO.2008.16.0259","article-title":"Monosomal karyotype in acute myeloid leukemia: a better indicator of poor prognosis than a complex karyotype","volume":"26","author":"Breems","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cancergen.2016.04.001_bib0035","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1182\/blood-2009-11-254441","article-title":"Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials","volume":"116","author":"Grimwade","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2016.04.001_bib0040","first-page":"3512","article-title":"A focused review of hematopoietic neoplasms occurring in the therapy-related setting","volume":"7","author":"Zhang","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.cancergen.2016.04.001_bib0045","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1182\/blood-2002-11-3343","article-title":"Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series","volume":"102","author":"Smith","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2016.04.001_bib0050","first-page":"1","article-title":"High p53 protein expression in therapy-related myeloid neoplasms is associated with adverse karyotype and poor outcome","volume":"153","author":"Cleven","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1016\/j.cancergen.2016.04.001_bib0055","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/sj.leu.2405078","article-title":"Genetics of therapy-related myelodysplasia and acute myeloid leukemia","volume":"22","author":"Pedersen-Bjergaard","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergen.2016.04.001_bib0060","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/gcc.2870140110","article-title":"Fluorescence in situ hybridization analysis of whole-arm 7;12 translocations in hematologic malignancies","volume":"14","author":"Johansson","year":"1995","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergen.2016.04.001_bib0065","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1038\/sj.leu.2404619","article-title":"Unbalanced translocation der(1;7)(q10;p10) defines a unique clinicopathological subgroup of myeloid neoplasms","volume":"21","author":"Sanada","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergen.2016.04.001_bib0070","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.cancergencyto.2008.05.015","article-title":"A new dic(7;12)(p12.21;p12.2) chromosome aberration in a case of acute myeloid leukemia","volume":"185","author":"Tapinassi","year":"2008","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergen.2016.04.001_bib0075","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.cancergencyto.2006.10.013","article-title":"Loss of 17p is a major consequence of whole-arm chromosome translocations in hematologic malignancies","volume":"173","author":"Adeyinka","year":"2007","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergen.2016.04.001_bib0080","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000357111","article-title":"der(5;17)(p10;q10) is a recurrent but rare whole-arm translocation in patients with hematological neoplasms: a report of three cases","volume":"132","author":"Manabe","year":"2014","journal-title":"Acta Haematol"},{"key":"10.1016\/j.cancergen.2016.04.001_bib0085","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/(SICI)1098-2264(199912)26:4<336::AID-GCC8>3.0.CO;2-H","article-title":"Combined spectral karyotyping and DAPI banding analysis of chromosome abnormalities in myelodysplastic syndrome","volume":"26","author":"Kakazu","year":"1999","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergen.2016.04.001_bib0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cancergencyto.2007.01.013","article-title":"Fluorescence in situ hybridization analysis of 110 hematopoietic disorders with chromosome 5 abnormalities: do de novo and therapy-related myelodysplastic syndrome-acute myeloid leukemia actually differ?","volume":"176","author":"Lessard","year":"2007","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergen.2016.04.001_bib0095","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.cancergencyto.2010.01.018","article-title":"Clonal evolution with double Ph followed by tetraploidy in imatinib-treated chronic myeloid leukemia with e19a2 transcript in transformation","volume":"199","author":"Oshikawa","year":"2010","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergen.2016.04.001_bib0100","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.5858\/2009-0015-OA.1","article-title":"Myelodysplastic syndromes arising in patients with germline TP53 mutation and Li-Fraumeni syndrome","volume":"134","author":"Talwalkar","year":"2010","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.cancergen.2016.04.001_bib0105","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/gcc.1212","article-title":"Identification of cytogenetic subclasses and recurring chromosomal aberrations in AML and MDS with complex karyotypes using M-FISH","volume":"33","author":"Van Limbergen","year":"2002","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergen.2016.04.001_bib0110","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1182\/blood-2012-03-419622","article-title":"A novel hierarchical prognostic model of AML solely based on molecular mutations","volume":"120","author":"Grossmann","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2016.04.001_bib0115","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1056\/NEJMoa1112304","article-title":"Prognostic relevance of integrated genetic profiling in acute myeloid leukemia","volume":"366","author":"Patel","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cancergen.2016.04.001_bib0120","doi-asserted-by":"crossref","first-page":"908","DOI":"10.3324\/haematol.2012.076729","article-title":"Mutational analysis of therapy-related myelodysplastic syndromes and acute myelogenous leukemia","volume":"98","author":"Shih","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.cancergen.2016.04.001_bib0125","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/bjh.12964","article-title":"The spectrum of somatic mutations in high-risk acute myeloid leukaemia with -7\/del(7q)","volume":"166","author":"McNerney","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cancergen.2016.04.001_bib0130","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1182\/asheducation-2007.1.392","article-title":"Genetic pathways in the pathogenesis of therapy-related myelodysplasia and acute myeloid leukemia","author":"Pedersen-Bjergaard","year":"2007","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.cancergen.2016.04.001_bib0135","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.leukres.2014.12.006","article-title":"Mutational profiling of therapy-related myelodysplastic syndromes and acute myeloid leukemia by next generation sequencing, a comparison with de novo diseases","volume":"39","author":"Ok","year":"2015","journal-title":"Leuk Res"},{"key":"10.1016\/j.cancergen.2016.04.001_bib0140","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerlow","year":"2008"},{"key":"10.1016\/j.cancergen.2016.04.001_bib0145","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1182\/blood-2012-03-420489","article-title":"Revised international prognostic scoring system for myelodysplastic syndromes","volume":"120","author":"Greenberg","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2016.04.001_bib0150","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1182\/blood-2010-04-279794","volume":"116","author":"Miesner","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2016.04.001_bib0155","series-title":"An International System for Human Cytogenetic Nomenclature (ISCN)","year":"2013"},{"key":"10.1016\/j.cancergen.2016.04.001_bib0160","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13045-015-0139-z","article-title":"TP53 mutation characteristics in therapy-related myelodysplastic syndromes and acute myeloid leukemia is similar to de novo diseases","volume":"8","author":"Ok","year":"2015","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.cancergen.2016.04.001_bib0165","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1182\/blood.V95.6.2138","article-title":"Deletions of chromosome 5q13.3 and 17p loci cooperate in myeloid neoplasms","volume":"95","author":"Castro","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2016.04.001_bib0170","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/gcc.10088","article-title":"Loss of genetic material is more common than gain in acute myeloid leukemia with complex aberrant karyotype: a detailed analysis of 125 cases using conventional chromosome analysis and fluorescence in situ hybridization including 24-color FISH","volume":"35","author":"Schoch","year":"2002","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergen.2016.04.001_bib0175","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1002\/gcc.21993","article-title":"Incidence of 17p deletions and TP53 mutation in myelodysplastic syndrome and acute myeloid leukemia with 5q deletion","volume":"51","author":"Sebaa","year":"2012","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergen.2016.04.001_bib0180","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1182\/blood-2011-08-375758","article-title":"TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome","volume":"119","author":"Rucker","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2016.04.001_bib0185","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/bjh.12203","article-title":"TP53 mutations in myelodysplastic syndrome are strongly correlated with aberrations of chromosome 5, and correlate with adverse prognosis","volume":"160","author":"Kulasekararaj","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cancergen.2016.04.001_bib0190","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1002\/pbc.24417","article-title":"Identification of TP53 as an acute lymphocytic leukemia susceptibility gene through exome sequencing","volume":"60","author":"Powell","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.cancergen.2016.04.001_bib0195","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/nature13968","article-title":"Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia","volume":"518","author":"Wong","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.cancergen.2016.04.001_bib0200","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/mc.10159","article-title":"TP53 is frequently altered by methylation, mutation, and\/or deletion in acute lymphoblastic leukaemia","volume":"38","author":"Agirre","year":"2003","journal-title":"Mol Carcinog"},{"key":"10.1016\/j.cancergen.2016.04.001_bib0205","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1038\/leu.2008.143","article-title":"Mutations of the TP53 gene in acute myeloid leukemia are strongly associated with a complex aberrant karyotype","volume":"22","author":"Haferlach","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergen.2016.04.001_bib0210","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1182\/blood-2014-02-558833","article-title":"TP53 mutations occur in 15.7% of ALL and are associated with MYC-rearrangement, low hypodiploidy, and a poor prognosis","volume":"124","author":"Stengel","year":"2014","journal-title":"Blood"}],"container-title":["Cancer Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776216300400?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776216300400?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:40:35Z","timestamp":1761896435000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210776216300400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S2210776216300400"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergen.2016.04.001","relation":{},"ISSN":["2210-7762"],"issn-type":[{"value":"2210-7762","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Whole-arm translocation of der(5;17)(p10;q10) with concurrent TP53 mutations in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS): A unique molecular-cytogenetic subgroup","name":"articletitle","label":"Article Title"},{"value":"Cancer Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cancergen.2016.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}